Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 质子泵 / Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 {[allProObj[0].p_purity_real_show]}

货号:A157451 同义名: 三水埃索美拉唑镁 / (S)-Omeprazole magnesium trihydrate; (-)-Omeprazole magnesium trihydrate

Esomeprazole magnesium trihydrate可抑制 H+/K+ ATP 酶,减少胃壁细胞的酸分泌。

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 化学结构 CAS号:217087-09-7
Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 化学结构
CAS号:217087-09-7
Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 3D分子结构
CAS号:217087-09-7
Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 化学结构 CAS号:217087-09-7
Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 3D分子结构 CAS号:217087-09-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 纯度/质量文件 产品仅供科研

货号:A157451 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Proton Pump 其他靶点 纯度
Zinc pyrithione 98+%
PF 03716556 ++++

H+/K+-ATPase, pIC50: ~6.5

99%
Lansoprazole 98%
Esomeprazole Magnesium 98%+
Rabeprazole 99%+
Ilaprazole TOPK 97%
Bafilomycin A1 ++++

H+-ATPase, IC50: 0.44 nM

99%
Pantoprazole sodium 98%
(R)-Lansoprazole 98%
Tenatoprazole 99%+
Omeprazole 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 生物活性

描述 Magnesium trihydrate ((S)-Omeprazole magnesium trihydrate) is a potent and orally active H+, K+-ATPase inhibitor. Esomeprazole magnesium trihydrate demonstrates promise in the research of upper intestinal disorders and gastroesophageal reflux disease[1].[2]. Through the suppression of V-H+-ATPases, Esomeprazole magnesium trihydrate functions as an inhibitor of exosomes, preventing their release[4].
体内研究

Treatment with Esomeprazole magnesium (0.5-50 mg/kg; orally via gavage; daily; over 10 days; in A/J mice) leads to an enhancement in gastric total antioxidant capacity and the activity of Cu/Zn-superoxide dismutase[1].

体外研究

Esomeprazole magnesium trihydrate was developed from Esomeprazole strontium tetrahydrate (EST), which includes esomeprazole, the S-enantiomer of omeprazole, and represents a salt-exchanged form of Esomeprazole magnesium trihydrate[2].

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 细胞实验

Cell Line
Concentration Treated Time Description References
primary human umbilical vein endothelial cells (HUVECs) 100 μmol/L 24 hours Esomeprazole MH reduced sFLT-1 secretion, but MTH had no significant effect Int J Mol Sci. 2022 Aug 23;23(17):9533
primary cytotrophoblast cells 100 μmol/L 24 hours Reduced secretion of sFLT-1 and mRNA expression of sFLT1-e15a and sFLT1-i13 Int J Mol Sci. 2022 Aug 23;23(17):9533

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice L-NAME-induced hypertension model Intraperitoneal injection 10 mg/kg Daily from D7.5 to D17.5 of pregnancy To assess the effect of esomeprazole on L-NAME-induced hypertension model, results showed esomeprazole did not lower blood pressure but enhanced ex vivo acetylcholine-induced vasorelaxation in obese mice. Int J Mol Sci. 2022 Jul 25;23(15):8185
Sprague Dawley (SD) rats Water-immersed and restraint (WIR)-induced stress ulcer model Intraperitoneal injection High dose 50 mg/kg/day, low dose 10 mg/kg/day Once daily for 7 days Esomeprazole pretreatment alleviates WIR-induced stress ulcer damage by inhibiting gastric acid secretion, exerting antioxidant and anti-inflammatory effects, and inactivating the p38 MAPK and NF-κB signaling pathways. Drug Des Devel Ther. 2019 Aug 22;13:2969-2984

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 参考文献

[1]Timothy R Koch, et al. Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice. J Nutr Biochem. 2004 Sep;15(9):522-6.

[2]Pankaj Kumar, et al. Preparation and characterization of pH-sensitive methyl methacrylate-g-starch/hydroxypropylated starch hydrogels: in vitro and in vivo study on release of esomeprazole magnesium. Drug Deliv Transl Res. 2015 Jun;5(3):243-56.

[3]Huarui Zhang, et al. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330.

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.30mL

0.26mL

0.13mL

6.52mL

1.30mL

0.65mL

13.03mL

2.61mL

1.30mL

Esomeprazole magnesium trihydrate/埃索美拉唑镁三水合物 技术信息

CAS号217087-09-7
分子式C34H42MgN6O9S2
分子量 767.17
SMILES Code CC(C=N1)=C(OC)C(C)=C1CS(C2=NC3=C([N-]2)C=C(OC)C=C3)=O.CC(C=N4)=C(OC)C(C)=C4CS(C5=NC6=C([N-]5)C=C(OC)C=C6)=O.[Mg+2].O.O.O
MDL No. MFCD07698573
别名 三水埃索美拉唑镁 ;(S)-Omeprazole magnesium trihydrate; (-)-Omeprazole magnesium trihydrate; Esomeprazole magnesium(trihydrate)
运输蓝冰
InChI Key VEVZQDGATGBLIC-UHFFFAOYSA-N
Pubchem ID 130565
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

溶解方案

DMSO: 50 mg/mL(65.17 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。